AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Krezsita 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Krezlin Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Krezsita 50/1000 Tablet

Diabex Duo 50/1000 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like vision loss and kidney disease, potentially lowering the risk of stroke or heart attack. Diabex Duo 50/1000 may be used alone or with other diabetes treatments, and its efficacy is enhanced by a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood sugar readings, and concurrent medications. Taking it with food minimizes stomach upset. Consistent daily dosing, at the same time, maximizes benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and pharyngitis. Hypoglycemia, a potential side effect when combined with insulin or sulfonylureas, requires awareness and appropriate management strategies. This medication isn't universally suitable. Prior to use, disclose any history of liver, kidney, or heart disease; pancreatic issues; or significant alcohol consumption. Pregnant or lactating individuals should consult their physician. Inform your doctor of all medications you're using, as interactions may occur. Alcohol should be limited due to its potential to lower blood sugar. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Krezsita 50/1000 Tablet

The provided text is "undefined," which has no meaning to rephrase. Therefore, no rewritten text can be provided.

Uses of Krezsita 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Krezsita 50/1000 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Krezsita 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Krezsita 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Krezsita 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Krezsita 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with meals.

How Krezsita 50/1000 Tablet works:

Krezsita 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Krezsita 50/1000 Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Krezsita 50/1000 tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Krezsita 50/1000 tablets are likely incompatible. Available data from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Krezsita 50/1000 Tablet, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician before use. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely abstain from Krezsita 50/1000 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Krezsita 50/1000 Tablet :

Should you forget a Krezsita 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Krezsita 50/1000 Tablet

LabelValue
Addictive No.
Treatment Category Diabetes Medication

FAQs on Krezsita 50/1000 Tablet

Krezsita 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Krezsita 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Krezsita 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Krezsita 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Krezsita 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Krezsita 50/1000 Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Krezsita 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. Krezsita 50/1000 is not suitable for individuals under 18.
Krezsita 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Krezsita 50/1000 Tablet is contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Krezsita 50/1000 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Krezsita 50/1000 Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Krezsita 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Krezsita 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Krezsita 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Krezsita 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Krezsita 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Krezsita 50/1000 Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Krezsita 50/1000 Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Krezsita 50/1000 Tablet
102